Surgical Management and Outcomes of Elderly Patients With Early Stage Non-small Cell Lung Cancer A Nested Case-Control Study

被引:55
作者
Rivera, Caroline [1 ]
Falcoz, Pierre-Emmanuel [2 ]
Bernard, Alain [3 ]
Thomas, Pascal A. [4 ]
Dahan, Marcel [5 ]
机构
[1] Univ Bordeaux, CHU Bordeaux, Haut Leveque Hosp, Dept Thorac Surg, Bordeaux, France
[2] Univ Strasbourg, Civil Hosp, Dept Thorac Surg, Strasbourg, France
[3] Univ Dijon, Bocage Hosp, Dept Thorac Surg, F-21004 Dijon, France
[4] Univ Marseille, North Hosp, Dept Thorac Surg, Marseille, France
[5] Univ Toulouse, Larrey Hosp, Dept Thorac Surg, Toulouse, France
关键词
PULMONARY RESECTION; WEDGE RESECTION; AGE; OCTOGENARIANS; MORTALITY; LOBECTOMY; RISK; SURVIVAL;
D O I
10.1378/chest.10-2841
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The number of oncogeriatric patients with non-small cell lung cancer (NSCLC) is expected to increase in the next decades. Methods: We used the French Society of Thoracic and Cardiovascular Surgery database Epithor that includes information on >140,000 procedures from 98 institutions. We prospectively collected data from January 2004 to December 2008 on 1 969 patients aged >= 70 years with NSCLC stage I or II and matched them with 1,969 control subjects aged <70 years for sex, American Society of Anesthesia score, performance status, and FEV1. Surgical treatment and postoperative outcomes were compared between the two age groups. Results: The absence of radical lymphadenectomy was more frequent in the older patients (14%, n = 269) than in the younger patients (9%, n = 170) (P < .0001). There was no significant difference in type of resection between older and younger patients, respectively (pneumonectomy, 8% [n = 164] vs 11% [n = 216]; lobectomy, 79% [n = 1,559] vs 77% [n = 1,521]; bilobectomy, 4% [n = 88] vs 5% [n = 97]; sublobar resection, 7% [n = 143] vs 6% [n = 118]; P = .08). Differences in number (P = .07) and severity (P = .69) of complications were not significant. Postoperative mortality was higher in elderly patients at every end point (30-day mortality, 3.6% [n = 70] vs 2.2% [n = 43] [P = .01]; 60-day mortality, 4.1% [n = 80] vs 2.4% [n = 47] [P = .003]; 90-day mortality, 4.7% [n = 93] vs 2.5% [n = 50] [P = .0002]). Conclusions: Elderly patients with NSCLC should not he denied pulmonary resection on the basis of chronologic age alone. Among patients aged >= 70 years, 90-day mortality compared acceptably with mortality among younger matched patients. Additionally, the data show that for older patients, a 90-day mortality better represents their real mortality risk than 30- or 60-day figures. Our contemporary, multiinstitutional data importantly reveal that elderly patients, compared with their younger counterparts, do not have increased morbidity, incidence, or severity after pulmonary resection. CHEST 2011; 140(4):874-880
引用
收藏
页码:874 / 880
页数:7
相关论文
共 50 条
  • [21] Surgical treatment of Early Non-Small Cell Lung Cancer in special groups of patients is superior to stereotactic radiotherapy
    Baltayiannis, Nikolaos
    Lagoudellis, Andreas
    Douvlis, Christos
    Gavalaki, Aikaterini
    Batika, Pelagia
    Petala, Xrysoula
    Pavlakou, Afroditi
    Chatzimichalis, Antonios
    SCIENTIFIC CHRONICLES, 2021, 26 (01) : 7 - 20
  • [22] Elevated serum lipid level can serve as early signal for metastasis for Non-Small Cell Lung Cancer patients: A retrospective nested case-control study
    Li, Rixin
    Liu, Bin
    Liu, Yumei
    Liu, Yang
    He, Yang
    Wang, Duo
    Sun, Yunxiang
    Xu, Ying
    Yu, Qiong
    JOURNAL OF CANCER, 2020, 11 (23): : 7023 - 7031
  • [23] Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs
    Syed, Yusef A.
    Stokes, William
    Rupji, Manali
    Liu, Yuan
    Khullar, Onkar
    Sebastian, Nikhil
    Higgins, Kristin
    Bradley, Jeffrey D.
    Curran, Walter J., Jr.
    Ramalingam, Suresh
    Taylor, James
    Sancheti, Manu
    Fernandez, Felix
    Moghanaki, Drew
    CHEST, 2022, 161 (03) : 833 - 844
  • [24] Sublobar resections in early-stage non-small cell lung cancer
    Sahin, Murat
    Yenigun, Mustafa Bulent
    Kocaman, Gokhan
    Duman, Elif
    Sakalli, Mehmet Ali
    Ozkan, Murat
    Yuksel, Cabir
    Cangir, Ayten Kayl
    Kutlay, Hakan
    Akal, Murat
    Enon, Serkan
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 27 (03): : 367 - 373
  • [25] Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly
    Qiu, Chen
    Wang, Guanghui
    Xu, Jun
    Cui, Lixuan
    Dong, Wei
    Ni, Yang
    Qu, Xiao
    Du, Jiajun
    INTERNATIONAL JOURNAL OF SURGERY, 2017, 37 : 1 - 7
  • [26] Treatment Outcomes in Elderly with Advanced-Stage Non-small Cell Lung Cancer
    Tam, Terence Chi-Chun
    Ho, James Chung-Man
    Wong, Matthew King-Yan
    Wong, Wai-Mui
    Wang, Julie Kwan-Ling
    Lam, Jamie Chung-Mei
    Lui, Macy Mei-Sze
    Lam, Wah-Kit
    Ip, Mary Sau-Man
    Lam, David Chi-Leung
    LUNG, 2013, 191 (06) : 645 - 654
  • [27] Management of Early Stage Non-Small Cell Lung Cancer in High-Risk Patients
    Donington, Jessica S.
    Blasberg, Justin D.
    THORACIC SURGERY CLINICS, 2012, 22 (01) : 55 - +
  • [28] Surgical treatment of early stage non-small cell lung cancer by thoracoscopic segmental resection
    Seguin-Givelet, A.
    Lutz, J.
    Brian, E.
    Grigoroiu, M.
    Gossot, D.
    REVUE DES MALADIES RESPIRATOIRES, 2018, 35 (05) : 521 - 530
  • [29] Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer
    Gallina, Filippo Tommaso
    Taje, Riccardo
    Forcella, Daniele
    Corzani, Felicita
    Cerasoli, Virna
    Visca, Paolo
    Coccia, Cecilia
    Pierconti, Federico
    Sperduti, Isabella
    Cecere, Fabiana Letizia
    Cappuzzo, Federico
    Melis, Enrico
    Facciolo, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (08)
  • [30] Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients
    Zheng, Quan
    Zhou, Jian
    Zhang, Yuanjin
    Wang, Tengyong
    Wu, Dongsheng
    Pu, Qiang
    Mei, Jiandong
    Liao, Hu
    Liu, Lunxu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (10) : 2549 - 2560